SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Zogenix, Inc. Cancels IPO

August 5, 2008 | 
1 min read
Zogenix Inc., a San Diego-based drug company focused on pain management and CNS disorders, has withdrawn registration for an $86.25 million IPO, citing "general market conditions."
IPO
MORE ON THIS TOPIC
Halftone hands shake coins out of paper money. Modern collage. Concept of inflation, bankruptcy, poverty. Financial difficulties
Rare diseases
Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
August 13, 2026
 · 
2 min read
 · 
Tristan Manalac
Business bankruptcy assistance concept. businessman on a paper boat and rescues a drowning man vector
Bankruptcy
Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale
August 13, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of businessmen moving a mountain uphill. The men & mountain and background are on separate labeled layers.
Business
Behind the bell: Gearing up to go public
August 13, 2026
 · 
6 min read
 · 
Angela Gabriel
Words IPO (Initial public offering) with the trading data on the background.
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 12, 2026
 · 
1 min read
 · 
Gabrielle Masson